Plasminogen activators are proteins involved in the breakdown of blood clots. And an elevated level of plasminogen activator inhibitor-1 (PAI-1) is associated with an increased risk for cardiovascular disease and clotting. No PAI-1 inhibitors are currently available for clinical use, but a novel therapeutic approach using a targeted RNA aptamer drug that has been shown to block PAI-1 activity and prevent PAI-1-associated vascular events is described in emNucleic ...
Read MoreYou have just read an article categorized health
titled RNA Aptamer Drug Targeted to Plasminogen Activator Inhibitor.
Written by:
editor - Monday, June 23, 2014
There are currently no comments for "RNA Aptamer Drug Targeted to Plasminogen Activator Inhibitor"
Post a Comment